Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 0.9 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 1.14 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 1.35 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 1.36 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 1.72 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 1.5 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 2.01 | pmol/sample |
| - | 1,2-DG(33:1) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 2.41 | pmol/sample |
| - | 1,2-DG(33:1) | C | 0.0 | BCD100322A01 | 1.09 | pmol/sample |
| - | 1,2-DG(33:1) | C | 0.5 | BCD100322A03 | 1.23 | pmol/sample |
| - | 1,2-DG(33:1) | C | 1.0 | BCD100322A07 | 1.31 | pmol/sample |
| - | 1,2-DG(33:1) | C | 2.0 | BCD100322A11 | 2.64 | pmol/sample |
| - | 1,2-DG(33:1) | C | 4.0 | BCD100322A15 | 1.85 | pmol/sample |
| - | 1,2-DG(33:1) | C | 8.0 | BCD100322A19 | 2.01 | pmol/sample |
| - | 1,2-DG(33:1) | C | 12.0 | BCD100322A23 | 1.66 | pmol/sample |
| - | 1,2-DG(33:1) | C | 24.0 | BCD100322A27 | 0.99 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 0.83 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 2.61 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.29 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 1.51 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 1.32 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 2.16 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 1.68 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 0.5 | BCD100322A04 | 1.08 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 1.0 | BCD100322A08 | 1.11 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 2.0 | BCD100322A12 | 1.32 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 4.0 | BCD100322A16 | 0.97 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 8.0 | BCD100322A20 | 1.61 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 12.0 | BCD100322A24 | 1.35 | pmol/sample |
| - | 1,2-DG(33:1) | 25OH-Chol | 24.0 | BCD100322A28 | 0.94 | pmol/sample |